Septerna, Common Stock Stock Today

SEPN Stock   25.29  0.51  2.06%   

Performance

18 of 100

 
Weak
 
Strong
Solid

Odds Of Distress

Less than 9

 
High
 
Low
Low
Septerna, Common is selling at 25.29 as of the 2nd of December 2024; that is 2.06 percent up since the beginning of the trading day. The stock's open price was 24.78. Septerna, Common has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Septerna, Common Stock are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of November 2024 and ending today, the 2nd of December 2024. Click here to learn more.
IPO Date
25th of October 2024
Category
Healthcare
Septerna, Common is entity of United States. It is traded as Stock on NASDAQ exchange. More on Septerna, Common Stock

Moving against Septerna, Stock

  0.6FRTX Fresh Tracks TherapeuticsPairCorr

Septerna, Stock Highlights

Business ConcentrationPharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Septerna, Common Stock (SEPN) is traded on NASDAQ Exchange in USA. It is located in 250 East Grand Avenue, South San Francisco, CA, United States, 94080 and employs 68 people. Septerna, Common is listed under Pharmaceutical Products category by Fama And French industry classification. The company conducts business under Healthcare sector and is part of Biotechnology industry.
Check Septerna, Common Probability Of Bankruptcy

Septerna, Common Historical Income Statement

View More Fundamentals

Septerna, Stock Against Markets

Septerna, Common Corporate Management

Daniel DPHILSenior DiscoveryProfile
MS MBAChief OfficerProfile
Uwe KleinSenior SciencesProfile
Richard HansenVice TechnologyProfile
David MartinSenior SciencesProfile
When determining whether Septerna, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Septerna, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Septerna, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Septerna, Common Stock Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Septerna, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Septerna, Common. If investors know Septerna, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Septerna, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Septerna, Common Stock is measured differently than its book value, which is the value of Septerna, that is recorded on the company's balance sheet. Investors also form their own opinion of Septerna, Common's value that differs from its market value or its book value, called intrinsic value, which is Septerna, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Septerna, Common's market value can be influenced by many factors that don't directly affect Septerna, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Septerna, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Septerna, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Septerna, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.